KMID : 0606920200280020131
|
|
Biomolecules & Therapeutics 2020 Volume.28 No. 2 p.131 ~ p.136
|
|
Spinosin Attenuates Alzheimer¡¯s Disease-Associated Synaptic Dysfunction via Regulation of Plasmin Activity
|
|
Cai Mudan
Jung In-Ho Kwon Hui-Young Cho Eun-Bi Jeon Ji-Eun Yun Jean-Ho Lee Young-Choon Kim Dong-Hyun Ryu Jong-Hoon
|
|
Abstract
|
|
|
Hippocampal synaptic dysfunction is a hallmark of Alzheimer¡¯s disease (AD). Many agents regulating hippocampal synaptic plasticity show an ameliorative effect on AD pathology, making them potential candidates for AD therapy. In the present study, we investigated spinosin as a regulating agent of synaptic plasticity in AD. Spinosin attenuated amyloid ¥â (A¥â)-induced long-term potentiation (LTP) impairment, and improved plasmin activity and protein level in the hippocampi of 5XFAD mice, a transgenic AD mouse model. Moreover, the effect of spinosin on hippocampal LTP in 5XFAD mice was prevented by 6-aminocaproic acid, a plasmin inhibitor. These results suggest that spinosin improves synaptic function in the AD hippocampus by regulating plasmin activity.
|
|
KEYWORD
|
|
Spinosin, Alzheimer¡¯s disease, Plasmin, LTP, 5XFAD
|
|
FullTexts / Linksout information
|
|
|
|
Listed journal information
|
|
|